Search Results - "GLENNON, Richard A"

Refine Results
  1. 1

    Predicting new molecular targets for known drugs by Shoichet, Brian K, Roth, Bryan L, Keiser, Michael J, Setola, Vincent, Irwin, John J, Laggner, Christian, Abbas, Atheir I, Hufeisen, Sandra J, Jensen, Niels H, Kuijer, Michael B, Matos, Roberto C, Tran, Thuy B, Whaley, Ryan, Glennon, Richard A, Hert, Jérôme, Thomas, Kelan L. H, Edwards, Douglas D

    Published in Nature (London) (12-11-2009)
    “…Although drugs are intended to be selective, at least some bind to several physiological targets, explaining side effects and efficacy. Because many…”
    Get full text
    Journal Article
  2. 2

    Binding and functional structure-activity similarities of 4-substituted 2,5-dimethoxyphenyl isopropylamine analogues at 5-HT2A and 5-HT2B serotonin receptors by Hemanth, Prithvi, Nistala, Pallavi, Nguyen, Vy T., Eltit, Jose M., Glennon, Richard A., Dukat, Małgorzata

    Published in Frontiers in pharmacology (24-01-2023)
    “…Certain 4-substituted analogs of 1-(2,5-dimethoxyphenyl)isopropylamine (2,5-DMA) are psychoactive classical hallucinogens or serotonergic psychedelic agents…”
    Get full text
    Journal Article
  3. 3

    “Deconstruction” of the Abused Synthetic Cathinone Methylenedioxypyrovalerone (MDPV) and an Examination of Effects at the Human Dopamine Transporter by Kolanos, Renata, Solis, Ernesto, Sakloth, Farhana, De Felice, Louis J, Glennon, Richard A

    Published in ACS chemical neuroscience (18-12-2013)
    “…Synthetic cathinones, β-keto analogues of amphetamine (or, more correctly, of phenylalkylamines), represent a new and growing class of abused substances…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Neurobiology of 3,4-Methylenedioxypyrovalerone (MDPV) and α-Pyrrolidinovalerophenone (α-PVP) by Glennon, Richard A, Young, Richard

    Published in Brain research bulletin (01-09-2016)
    “…Highlights • Nomenclature of synthetic cathinones • Mechanism of action of MDPV and α PVP • Structure activity relationships for action as DAT reuptake…”
    Get full text
    Journal Article
  6. 6

    3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro by Setola, Vincent, Hufeisen, Sandra J, Grande-Allen, K Jane, Vesely, Ivan, Glennon, Richard A, Blough, Bruce, Rothman, Richard B, Roth, Bryan L

    Published in Molecular pharmacology (01-06-2003)
    “…Recent findings have implicated the 5-hydroxytryptamine 2B (5-HT2B) serotonin receptor in mediating the heart valve fibroplasia [valvular heart disease (VHD)]…”
    Get more information
    Journal Article
  7. 7
  8. 8

    The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The “Phenylalkylaminome” with a Focus on Selected Drugs of Abuse by Glennon, Richard A

    Published in Journal of medicinal chemistry (13-04-2017)
    “…The phenylalkylamine, particularly the phenylethylamine, moiety is a common structural feature found embedded in many clinically approved agents. Greater still…”
    Get full text
    Journal Article
  9. 9

    Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention by Glennon, Richard A

    Published in Advances in pharmacology (1990) (2014)
    “…The term "synthetic cathinones" is fairly new, but, although the abuse of synthetic cathinones is a recent problem, research on cathinone analogs dates back…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Deconstruction of the α4β2 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator Desformylflustrabromine by German, Nadezhda, Kim, Jin-Sung, Jain, Atul, Dukat, Malgorzata, Pandya, Anshul, Ma, Yilong, Weltzin, Maegan, Schulte, Marvin K, Glennon, Richard A

    Published in Journal of medicinal chemistry (27-10-2011)
    “…Desformylflustrabromine (dFBr; 1), perhaps the first selective positive allosteric modulator of α4β2 neuronal nicotinic acetylcholine (nACh) receptors, was…”
    Get full text
    Journal Article
  12. 12

    The medicinal chemistry of 5-HT6 receptor ligands with a focus on arylsulfonyltryptamine analogs by Glennon, Richard A, Siripurapu, Uma, Roth, Bryan L, Kolanos, Renata, Bondarev, Mikhail L, Sikazwe, Donald, Lee, Mase, Dukat, Małgorzata

    Published in Current topics in medicinal chemistry (01-04-2010)
    “…Arylsulfonyl analogs of aminopyrimidines (e.g. Ro 04-6790; 2), aminopyridines (e.g. Ro 63-0563; 3), 1-phenylpiperazines (e.g. SB-271046; 4), and tryptamines…”
    Get more information
    Journal Article
  13. 13

    Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor by Setola, Vincent, Dukat, Malgorzata, Glennon, Richard A, Roth, Bryan L

    Published in Molecular pharmacology (01-07-2005)
    “…S-(+)-Norfenfluramine (SNF)-an active metabolite of the now-banned anorexigen fenfluramine-has been implicated in the drug's appetite-suppressing actions and…”
    Get more information
    Journal Article
  14. 14

    Quipazine: Classical hallucinogen? Novel psychedelic? by Glennon, Richard A, Dukat, Maƚgorzata

    Published in Critical studies in media communication (02-05-2023)
    “…Quipazine, first identified in the 1960s, has been the topic of >1000 published papers. On the basis of available 5-HT2 serotonin receptor radioligand binding…”
    Get full text
    Journal Article
  15. 15

    Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of “bath salts,” produce opposite effects at the human dopamine transporter by Cameron, Krasnodara, Kolanos, Renata, Verkariya, Rakesh, De Felice, Louis, Glennon, Richard A.

    Published in Psychopharmacology (01-06-2013)
    “…Rationale Psychoactive “bath salts” represent a relatively new drug of abuse combination that was placed in Schedule I in October 2011. Two common ingredients…”
    Get full text
    Journal Article
  16. 16

    1‑(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents – A Review by Glennon, Richard A., Dukat, Małgorzata

    Published in ACS pharmacology & translational science (14-06-2024)
    “…1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI, or DOX where X = −I) was first synthesized in 1973 in a structure–activity study to explore the effect of…”
    Get full text
    Journal Article
  17. 17

    Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter by Cameron, Krasnodara N, Kolanos, Renata, Solis, Ernesto, Glennon, Richard A, De Felice, Louis J

    Published in British journal of pharmacology (01-04-2013)
    “…Background and Purpose Bath salts is the street name for drug combinations that contain synthetic cathinone analogues, among them possibly mephedrone (MEPH)…”
    Get full text
    Journal Article
  18. 18

    Behavioral and biochemical investigations of bupropion metabolites by Bondarev, Mikhail L, Bondareva, Tatiana S, Young, Richard, Glennon, Richard A

    Published in European journal of pharmacology (01-08-2003)
    “…The stimulus effects of bupropion metabolites were examined in a drug discrimination procedure using (−)nicotine- and (+)amphetamine-trained rats. (+)- and (−)…”
    Get full text
    Journal Article
  19. 19

    Synthetic cathinones: Chemical phylogeny, physiology, and neuropharmacology by De Felice, Louis J., Glennon, Richard A., Negus, Sidney S.

    Published in Life sciences (1973) (27-02-2014)
    “…This mini-review summarizes the history of cathinone and its synthesized derivatives from early records to the present day, including the appearance of…”
    Get full text
    Journal Article
  20. 20

    Non-conserved residues dictate dopamine transporter selectivity for the potent synthetic cathinone and psychostimulant MDPV by Steele, Tyler W.E., Spires, Zachary, Jones, Charles B., Glennon, Richard A., Dukat, Małgorzata, Eltit, Jose M.

    Published in Neuropharmacology (01-12-2021)
    “…Clandestine chemists are currently exploiting the pyrrolidinophenone scaffold to develop new designer drugs that carry the risk of abuse and overdose. These…”
    Get full text
    Journal Article